scholarly journals Co-morbidity in older patients with COPD—its impact on health service utilisation and quality of life, a community study

2006 ◽  
Vol 35 (1) ◽  
pp. 33-37 ◽  
Author(s):  
J. Yeo ◽  
G. Karimova ◽  
S. Bansal
2018 ◽  
Vol 27 (6) ◽  
pp. e12926
Author(s):  
Man Yu Wong ◽  
Yingsi Yang ◽  
Zhiqiang Cao ◽  
Vivian Y. W. Guo ◽  
Cindy L. K. Lam ◽  
...  

2007 ◽  
Vol 27 (9) ◽  
pp. 859-863 ◽  
Author(s):  
Thomas Rosemann ◽  
Jochen Gensichen ◽  
Nina Sauer ◽  
Gunter Laux ◽  
Joachim Szecsenyi

2021 ◽  
Vol 9 (2) ◽  
pp. 31
Author(s):  
Christine E. Mc Carthy

Sleep complaints can be both common and complex in the older patient. Their consideration is an important aspect of holistic care, and may have an impact on quality of life, mortality, falls and disease risk. Sleep assessment should form part of the comprehensive geriatric assessment. If sleep disturbance is brought to light, consideration of sleep disorders, co-morbidity and medication management should form part of a multifaceted approach. Appreciation of the bi-directional relationship and complex interplay between co-morbidity and sleep in older patients is an important element of patient care. This article provides a brief overview of sleep disturbance and sleep disorders in older patients, in addition to their association with specific co-morbidities including depression, heart failure, respiratory disorders, gastro-oesophageal reflux disease, nocturia, pain, Parkinson’s disease, dementia, polypharmacy and falls. A potential systematic multidomain approach to assessment and management is outlined, with an emphasis on non-pharmacological treatment where possible.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Antonio Preti ◽  
Roberto Demontis ◽  
Giulia Cossu ◽  
Goce Kalcev ◽  
Federico Cabras ◽  
...  

Abstract Background Generalized anxiety disorder (GAD) is one of the most reported diagnoses in psychiatry, but there is some discrepancy between the cases identified in community studies and those identified in tertiary care. This study set out to evaluate whether the use of clinicians as interviewers may provide estimates in a community survey close to those observed in primary or specialized care. Methods This is a community survey on a randomly selected sample of 2338 adult subjects. The Advanced Neuropsychiatric Tools and Assessment Schedule (ANTAS) was administered by clinicians, providing lifetime diagnosis based on the DSM-IV-TR. Health-related quality of life (HR-QoL) was measured with the Short-Form Health Survey (SF-12). Results Overall, 55 (2.3%) subjects met the criteria for GAD, with greater prevalence in women (3.6%) than in men (0.9%): OR = 4.02; 95%CI: 1.96–8.26. Up to 40% of those with GAD had at least another diagnosis of mood, anxiety, or eating disorders. The mean score of SF-12 in people with GAD was 32.33 ± 6.8, with a higher attributable burden than in other conditions except for major depressive disorder. Conclusions We found a relatively lower lifetime prevalence of GAD than in community surveys based on lay interviewers and a structured interview. The identified cases of GAD showed a strong impact on the quality of life regardless of co-morbidity and high risk in women, suggesting a profile similar to the one identified from studies in primary and specialized care.


Sign in / Sign up

Export Citation Format

Share Document